Dr. Torabian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2345 Fair Oaks Blvd
Sacramento, CA 95825Phone+1 916-480-6869
Summary
- Dr. Sima Torabian is a dermatologist based in Sacramento, CA. She completed her residency in dermatology at the University of California Davis Health after an internship in internal medicine at the University of New Mexico School of Medicine. She graduated from the University of California, Davis, School of Medicine in 2003. Dr. Torabian has contributed to several notable publications primarily focused on melanoma, with her research being cited multiple times in the scientific community. She received the Meaningful Use Stage 1 Certification from the Centers for Medicare & Medicaid Services in 2011.
Education & Training
University of California Davis HealthResidency, Dermatology, 2005 - 2008
University of New Mexico School of MedicineInternship, Internal Medicine, 2003 - 2004
University of California, Davis, School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2006 - 2025
NM State Medical License 2003 - 2004
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 73 citationsA multi-marker assay to distinguish malignant melanomas from benign neviMohammed Kashani-Sabet, Javier Rangel, Sima Torabian, Mehdi Nosrati, Jeff Simko
Proceedings of the National Academy of Sciences of the United States of America. 2009-04-14 - 7 citationsRibozyme-Mediated Targeting of IκBγ Inhibits Melanoma Invasion and MetastasisSima Torabian, David de Semir, Mehdi Nosrati, Sepideh Bagheri, Altaf A. Dar
The American Journal of Pathology. 2009-03-01 - 83 citationsOsteopontin as a molecular prognostic marker for melanoma.Javier Rangel, Mehdi Nosrati, Sima Torabian, Ladan Shaikh, Stanley P. L. Leong
Cancer. 2008-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
